EU follows U.S. in backing Sanofi, Regeneron eczema drug

LONDON, July 21 (Reuters) - The European Medicines Agency on Friday recommended approval of Regeneron Pharmaceuticals and Sanofi's new drug Dupixent for atopic dermatitis, a product many analysts see as the most important growth driver for the two companies.